Search

everythinglearnresearchcommunity

for

Search:↓

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Women with PCOS have higher levels of thyroid autoantibodies.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

Finasteride can cause serious mental health issues, so it's advised to avoid it for hair loss.

Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.

Isotretinoin effectively treats severe acne but has serious side effects and requires careful monitoring.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

Finasteride can cause long-term side effects like sexual dysfunction and depression.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Women with polycystic ovarian syndrome often experience depression and anxiety.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Long-term parenteral nutrition without zinc can cause severe zinc deficiency.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.